Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ndzhentiks

PRIVATE STATUS
Grant LATEST DEAL TYPE
$351K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of drugs for tuberculosis. The company develops drugs using a molecular-genetic platform for treating drug-resistant tuberculosis through semiconductor sequencing.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
  • ul. Aviakonstruktora Mikoyana, 12
  • Room 1
  • Moscow, 125252
  • Russia
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ndzhentiks’s full profile, request a free trial.

Ndzhentiks Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 02-Dec-2014 $351K 00000 Completed Startup
1. Angel (individual) 02-Dec-2014 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ndzhentiks Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Skolkovo Foundation Limited Partner 000 0000 000000 0